Muscle News and Research

RSS

Lowering systolic blood pressure can reduce risk of left ventricular hypertrophy

Lowering systolic blood pressure below the currently recommended target can reduce the risk of left ventricular hypertrophy (LVH), the most common complication of high blood pressure, according to new research.

14 Oct 2015

Brain areas linked to social behaviors underdeveloped in youths with high functioning ASD

A team of UCLA scientists has found that brain areas linked to social behaviors are both underdeveloped and insufficiently networked in youths with high functioning autism spectrum disorder (ASD) compared to study participants without ASD.

14 Oct 2015

MIT neuroscientists discover brain circuit that controls sleep

Sleep is usually considered an all-or-nothing state: The brain is either entirely awake or entirely asleep. However, MIT neuroscientists have discovered a brain circuit that can trigger small regions of the brain to fall asleep or become less alert, while the rest of the brain remains awake.

14 Oct 2015

Sleep apnea associated with evidence of early heart injury in women

Risk factors for obstructive sleep apnea (OSA) and the development of subsequent cardiovascular (CV) complications differ by sex, but it is not clear from prior research whether the effects of sleep apnea on heart disease is similar for men and women.

13 Oct 2015

New design could improve safety, efficiency of spinal surgery in children with cerebral palsy

Researchers have designed a way to improve the safety and efficiency of a complex surgical procedure for children with cerebral palsy by using wearable technology like Google Glass.

13 Oct 2015

Study: RNA editing technique shows promise in treating rare, severe form of muscular dystrophy

An RNA editing technique called "exon skipping" has shown preliminary success in treating a rare and severe form of muscular dystrophy that currently has no treatment, based on a new study from Northwestern Medicine and the University of Chicago. Children with the disease lose significant muscle strength early in life.

13 Oct 2015

NC State scientists take a giant leap closer to understanding locomotion from the leg up

Using an "Avatar"-like bio-robotic motor system that integrates a real muscle and tendon along with a computer controlled nerve stimulator acting as the avatar's spinal cord, North Carolina State University researchers have taken a giant leap closer to understanding locomotion from the leg up.

13 Oct 2015

IU investigators find how cancer-induced bone destruction triggers skeletal muscle weakness

Cancer researchers at Indiana University and their colleagues have discovered how cancer-induced bone destruction causes skeletal muscle weakness.

12 Oct 2015

Glycan binding proteins modify parasite infection in cells of the heart muscle

Chagas disease is the main cause of infectious heart disease in Latin America. Researchers from the INGEBI and IBYME Institutes in Argentina explored the effect of glycan binding protein interactions between the human host and Typanosoma cruzi parasite. They found that a glycan binding protein expressed in humans modified the infection in cells of the heart muscle, showing the importance of galectins in the response to parasite infection.

12 Oct 2015

Hi-Tech Pharmaceuticals signs definitive agreement to acquire iForce

Hi-Tech Pharmaceuticals, a leading global provider of Sports Nutrition products, Contract Manufacturing, and iForce Nutrition ("iForce"), one of the fastest-growing Sports Nutrition companies in the United States, today announced that they have entered into a definitive agreement in which Hi-Tech has agreed to acquire iForce.

9 Oct 2015

New partnership to deliver world-class healthcare through collaborative scientific research

A new partnership which harnesses world-class expertise will ensure patients benefit sooner from new treatments, diagnostics and prevention strategies.

9 Oct 2015

Vraylar (cariprazine) capsules now approved by FDA to treat schizophrenia, bipolar disorder in adults

The U.S. Food and Drug Administration today approved Vraylar (cariprazine) capsules to treat schizophrenia and bipolar disorder in adults.

9 Oct 2015

SynAgile announces positive results from Phase 2a trial of continuous intraoral LD/CD therapy

SynAgile Corporation, a privately held pharmaceutical company that develops and commercializes drug delivery systems using its proprietary OraFuse intraoral technology platform, today announced positive results from a proof-of-concept, Phase 2a, open-label clinical trial of continuous intraoral administration of levodopa-carbidopa (LD/CD).

8 Oct 2015

New report reveals more about how stem cells are affected by immediate surroundings

A Johns Hopkins University biologist has led a research team reporting progress in understanding the mysterious shape-shifting ways of stem cells, which have vast potential for medical research and disease treatment.

8 Oct 2015

NS1 protein can be considered as vital target for development of new drugs to treat dengue: Study

Dengue is a mosquito-borne tropical disease currently endemic in more than 10 countries. According to the World Health Organization, 390 million people are infected by dengue every year.

7 Oct 2015

Tarix Orphan's TXA127 granted FDA Fast Track Designation for treatment of DMD patients

Tarix Orphan LLC, a privately held biopharmaceutical company focused on the treatment of rare neuromuscular disorders and connective tissue diseases, today announced that the U.S. Food and Drug Administration has granted Fast Track Designation to TXA127 (angiotensin 1-7) to reduce skeletal muscle damage and fibrosis and thereby improve muscle strength in Duchenne Muscular Dystrophy (DMD) patients.

6 Oct 2015

Getting right nutrition throughout life can help protect against osteoporosis in old age

Whether you're young or old, the right nutrition can make a difference to your bone health and influence your ability to live an independent, mobile, fracture-free life into your more senior years. That's the key message of a new scientific review published today in the journal 'Osteoporosis International' by leading bone and nutrition experts, in anticipation of World Osteoporosis Day on October 20.

6 Oct 2015

U of T study provides hope for treating ALS and FTD

It's the most common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), but until now scientists weren't sure how a specific gene caused these devastating diseases. Now researchers from the University of Toronto are one step closer to solving this incredibly complex puzzle, offering hope for treatment.

6 Oct 2015

Insulin sensitivity of main glucose storage sites in the body improve following gastric bypass surgery

Roux-en-Y, the most common type of gastric bypass surgery, can lead to remission of type 2 diabetes along with weight loss. A new study in the American Journal of Physiology—Regulatory, Integrative and Comparative Physiology examines why, finding that insulin sensitivity of the main glucose (sugar) storage sites in the body improve after gastric bypass surgery.

5 Oct 2015

Clinical data from spinal muscular atrophy program presented at 20th International WMS Congress

PTC Therapeutics, Inc., today announced that clinical data from the company's joint development program with Roche and the SMA Foundation in spinal muscular atrophy (SMA) were presented at the 20th International Congress of the World Muscle Society (WMS) in Brighton, U.K.

5 Oct 2015

Muscle News and Research

Lowering systolic blood pressure can reduce risk of left ventricular hypertrophy

Brain areas linked to social behaviors underdeveloped in youths with high functioning ASD

MIT neuroscientists discover brain circuit that controls sleep

Sleep apnea associated with evidence of early heart injury in women

New design could improve safety, efficiency of spinal surgery in children with cerebral palsy

Study: RNA editing technique shows promise in treating rare, severe form of muscular dystrophy

NC State scientists take a giant leap closer to understanding locomotion from the leg up

IU investigators find how cancer-induced bone destruction triggers skeletal muscle weakness

Glycan binding proteins modify parasite infection in cells of the heart muscle

Hi-Tech Pharmaceuticals signs definitive agreement to acquire iForce

New partnership to deliver world-class healthcare through collaborative scientific research

Vraylar (cariprazine) capsules now approved by FDA to treat schizophrenia, bipolar disorder in adults

SynAgile announces positive results from Phase 2a trial of continuous intraoral LD/CD therapy

New report reveals more about how stem cells are affected by immediate surroundings

NS1 protein can be considered as vital target for development of new drugs to treat dengue: Study

Tarix Orphan's TXA127 granted FDA Fast Track Designation for treatment of DMD patients

Getting right nutrition throughout life can help protect against osteoporosis in old age

U of T study provides hope for treating ALS and FTD

Insulin sensitivity of main glucose storage sites in the body improve following gastric bypass surgery

Clinical data from spinal muscular atrophy program presented at 20th International WMS Congress

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News